A transgenic mouse allows characterization of the HLA-C∗06:02 immunopeptidome in a model of psoriasis.

Saved in:
Bibliographic Details
Title: A transgenic mouse allows characterization of the HLA-C∗06:02 immunopeptidome in a model of psoriasis.
Authors: Braun A; Infection and Immunity Programs, Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia. Electronic address: Asolina.Braun@monash.edu., Mobbs JI; Infection and Immunity Programs, Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia., Chung S; Infection and Immunity Programs, Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia., Tuomisto JE; Infection and Immunity Programs, Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia., Li C; Infection and Immunity Programs, Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia; Department of Medicine, School of Clinical Sciences, Monash University, Clayton, Australia., Scull KE; Infection and Immunity Programs, Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia., Ayala R; Infection and Immunity Programs, Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia., Anand S; Infection and Immunity Programs, Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia., Ramarathinam S; Infection and Immunity Programs, Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia., Kern JS; Department of Dermatology, Alfred Health, Melbourne, Australia; Department of Medicine, The School of Translational Medicine, Monash University, Melbourne, Australia., Fourie A; Janssen Research & Development, Raritan, New Jersey, USA., McKinnon M; Janssen Research & Development, Raritan, New Jersey, USA., Manthey C; Janssen Research & Development, Raritan, New Jersey, USA., Baker DG; Janssen Research & Development, Raritan, New Jersey, USA., Rao N; Janssen Research & Development, Raritan, New Jersey, USA., Mifsud NA; Infection and Immunity Programs, Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia., Illing PT; Infection and Immunity Programs, Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia., Vivian JP; Infection and Immunity Programs, Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia., Rossjohn J; Infection and Immunity Programs, Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia., Purcell AW; Infection and Immunity Programs, Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia. Electronic address: Anthony.Purcell@monash.edu.
Source: The Journal of investigative dermatology [J Invest Dermatol] 2026 Jul; Vol. 146 (7), pp. 1816-1826.e2. Date of Electronic Publication: 2025 Dec 24.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 0426720 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-1747 (Electronic) Linking ISSN: 0022202X NLM ISO Abbreviation: J Invest Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1523-1747
DOI:10.1016/j.jid.2025.12.015